RNS Number : 5779E
IMI PLC
23 October 2025
 

23 October 2025

 

IMI plc

 ("IMI" or the "Company")

Statement Regarding Shareholder Consultation Following the 2025 Annual General Meeting

 

At the Company's Annual General Meeting ("AGM") held on 8 May 2025, all proposed resolutions were duly passed by shareholders. However, Special Resolution B, relating to the authority to allot securities for cash for specific financing purposes, received 78.25% support, falling below the 80% threshold outlined in the UK Corporate Governance Code (the Code) for enhanced shareholder engagement.

In line with the Code, the Company contacted shareholders who were understood to have voted against the resolution to seek their views and better understand any concerns. Feedback received indicated that the lower level of support was primarily driven by institutional voting policies and concerns around potential dilution, particularly in the absence of a defined transaction for which the authority would be exercised.

The resolution was consistent with the Pre-Emption Group's 2022 Statement of Principles regarding the disapplication of pre-emption rights. The Board considered the flexibility afforded by the resolution to be in the best interests of the Company and its shareholders. Nonetheless, the Board remains committed to ongoing dialogue with shareholders and will continue to review its approach in this area. A further update will be provided in the Company's 2025 Annual Report. The Board is grateful to shareholders for their engagement and constructive feedback.

Enquiries to:

IMI

Edward Hann, Head of Investor Relations                             Tel: 07977 354 810

Fran Burge, Deputy Company Secretary                               Tel: 0121 717 3700

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFETIILVFIE